Form 4: Boston Scientific CEO Buys Shares
Insider Transaction (Form 4)
Michael F Mahoney, Chairman, President & CEO and a Director of Boston Scientific Corp, purchased 186,240 shares of common stock on August 3, 2026 for $48.33 per share.
Summary
- Open-market purchase: acquired 186,240 Common Stock at $48.33 ($9,001,408) on August 3, 2026; holds 1,590,024 after (Direct).
- Discretionary transaction: acquired 22,119 Common Stock at $48.43 ($1,071,223) on August 3, 2026; holds 22,119 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $9,001,408, committing personal capital to the stock.
Insider Transactions
Michael F Mahoney — Director, Officer (Chairman, President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Open-market purchase | Common Stock | 186,240 | $48 | $9.0M | 1,590,024 |
| 2026-08-03 | Discretionary transaction | Common Stock | 22,119 | $48 | $1.1M | 22,119 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Open-market purchase (186,240 shares) |
| 2026-08-03 | Discretionary transaction (22,119 shares) |
Keywords
insider transaction, Form 4, BSX, BOSTON SCIENTIFIC CORP, bullish, Michael F Mahoney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.